Angst J: Switch from depression to mania-a record study over decades between 1920 and 1982. Psychopathology 18(2-3):140–54, 1985.
Atre-Vaidya N, Taylor MA, Seidenberg M, Reed R, Perrine A, Glick-Oberwise F, Cognitive deficits, psychopathology, and psychosocial functioning in bipolar mood disorder. Neuropsychiatry, Neuropsychology, &; Behavioral Neurology 11(3):120–6, 1998.
Bellini L, Gambini O, Palladino F, Scarone S: Neuropsychological assessment of functional central nervous system disorders. I. Hemispheric functioning characteristics in schizophrenia and affective illness. Acta Psychiatrica Scandinavica 78(2):242–6, 1988 Aug.
Bratfos O, Haug JO: The course of manic-depressive psychosis: a follow-up investigation of 215 patients. Acta Psychiatr Scand 44:89–112, 1968.
Cannon M, Jones P, Gilvarry C, Rifkin L, McKenzie K, Foerster A, Murray RM: Premorbid social functioning in schizophrenia and bipolar disorder: similarities and differences. Am J Psychiatry 154:1544–1550, 1997.
Carlson GA, Kotin J, Davenport YM, et al.: Follow-up of 53 bipolar manic-depressive patients. Br J Psychiatry 124:134–139, 1974.
Coffman JA, Bornstein RA, Olson SC, Schwarzkopf SB, Nasrallah HA: Cognitive impairment and cerebral structure by MRI in bipolar disorder. Biol Psychiatry 1;27 (11):1188–96, 1990 Jun.
Cooke RG, Robb JC, Young LT, Joffee RT: Well-being and functioning in patients with bipolar disorder assessed using the MOS 20-item short form (SF-20). J Affect Disord 39:93–97, 1996.
Coryell W, Scheftner W, Keller M, et al.: The enduring psychosocial consequences of mania and depression. Am J Psychiatry 150:720–727, 1993.
Dion GL, Tohen M, Anthony WA, et al.: Symptoms and functioning of patients with bipolar disorder six months after hospitalization. Hosp Community Psychiatry 39:652–657, 1988.
Gallhofer B, Bauer U, Lis S, Krieger S, Gruppe H: Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs. Eur Neuropsychopharmacol 6(Suppl 2):S13–S20, 1996.
Ghaemi SN, Sachs GS: Long-term risperidone treatment in bipolar disorder: 6-month follow up. International Clinical Psychopharmacology 12(6):333–8, 1997 Nov.
Gitlin MJ, Swendson J, Heller TL, et al.: Relapse and impairment in bipolar disorder. Am J Psychiatry 152:1635–1640, 1995.
Goldberg JF, Garno JL, Leon AC, Kocsis JH, Portera L: A history of substance abuse complicates remission from acute mania in bipolar disorder. J Clin Psychiatry 60:733–740, 1999
Goldberg JF, Harrow M, Grossman LS: Course and outcome in bipolar affective disorder: a longitudinal follow-up study. Am J Psychiatry 152:379–384, 1995.
Goldberg JF, Harrow M, eds.: Bipolar Disorders. Clinical Course and Outcome. American Psychiatric Press, Inc. 1999, pg. 5
Goodnick PJ, Fieve RR: Plasma lithium level and interepisode functioning in bipolar disorder. American Journal of Psychiatry 142(6):761–2, 1985 Jun.
Goodwin FK, Jamison KR: Manic-Depressive Illness. New York: Oxford University Press. 1990.
Harrow M, Goldberg JF, Grossman LS, et al.: Outcome in manic disorders: a naturalistic follow-up study. Arch Gen Psychiatry 47:665–671, 1990.
Harvey PD, Powchick P, Parrella M, White L, Davidson M: Symptom severity and cognitive impairment in chronically hospitalized. geriatric patients with affective disorders. British Journal of Psychiatry 170:369–74, 1997 Apr.
Hawkins KA, Mohamed S, Woods SW: Will the novel antipsychotics significantly ameliorate neuropsychological deficits and improve adaptive functioning in schizophrenia? Psychol Med 29(1):1–8, 1999 Jan.
Hegarty JD, Baldessarini RJ, Tohen M, Waternaux CM, Oepen G: One hundred years of schizophrenia: A meta-analysis of the outcome literature. Am J Psychiatry 151:1409–1416, 1994.
Henry AD, Coster WJ: Predictors of functional outcome among adolescents and young adults with psychotic disorders. American Journal of Occupational Therapy 50(3):171–81, 1996 Mar.
Himmelhoch JM, Garfinkel ME: Sources of lithium resistance in mixed mania. Psychopharmacol Bull 22:613–620, 1986.
Joffe RT: MacDonald C: Kutcher SP: Lack of differential cognitive effects of lithium and carbamazepine in bipolar affective disorder. Journal of Clinical Psychopharmacology 8(6):425–8, 1988 Dec.
Keck PE Jr, McElroy SL, Strakowski SM, West SA, Sax KW, Hawkins JM, Bourne ML, Haggard P: 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry 155:646–652, 1998.
Keller MB, Lavori PW, Coryell W, Andreasen NC, Endicott J, Clayton PJ, Klerman GL, Hirschfeld RM: Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. Journal of the American Medical Association 255:3138–3142, 1986.
Kraepelin E: Manic-Depressive Insanity (1921). Translated by Barclay RM. Edinburgh, Scotland, Linvingstone. Reprint, New York, Arno Press, 1976.
Kukopulos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L: Course of the manic-depressive cycle and changes caused by treatments. Pharmakopsychiatr Neuropsychopharmakol 13:156–167, 1980.
Laroche I, Hodgins S, Toupin J: [Correlation between symptoms and social adjustment in patients suffering from schizophrenia or major affective disorder]. [French] Canadian Journal of Psychiatry-Revue Canadienne de Psychiatrie 40(1):27–34, 1995 Feb.
MacQueen GM, Young LT, Robb JC, Cooke RG, Joffe RT. Levels of functioning and well-being in recovered psychotic versus nonpsychotic mania. J Affect Disord 46:69–72 1997.
Mayfield D, Coleman LL: Alcohol use and affective disorder. Dis Nerv Syst 29:467–474, 1968.
Meltzer HY, Thompson PA, Lee MA, Ranjan R: Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment. Neuropsychopharmacology 14:27S–33S, 1996.
Meltzer HY, McGurk SR: The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25:233–55, 1999.
Morrison JR: Bipolar affective disorder and alcoholism. Am J Psychiatry 131:1130–1133, 1974.
O'Connell RA, Mayo JA, Flatow L, et al.: Outcome of bipolar disorder on longterm treatment with lithium. Br J psychiatry 159:123–129, 1991.
Paradiso S, Lamberty GJ, Garvey MJ, Robinson RG: Cognitive impairment in the euthymic phase of chronic unipolar depression. Journal of Nervous &; Mental Disease 185(12):748–54, 1997 Dec.
Purdon SE, Jones BD, Stip E, Labelle A, Addington D, David SR, Breier A, Tollefson GD: Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia. Arch Gen Psychiatry 57(3):249-58 200 Mar.
Rennie TAC. Prognosis in manic-depressive psychoses. Am J Psychiatry 98:801–814, 1942.
Robb JC, Young LT, Cooke RG, Joffe RT: Gender differences in patients with bipolar disorder influence outcome in the medical outcomes survey (SF-20) subscale scores. Journal of Affective Disorders. 49(3):189–93, 1998.
Rosen LN, Rosenthal NE, Dunner DL, Fieve RR: Social outcome compared in psychotic and nonpsychotic bipolar I patients. J Nerv Ment Dis 171(5):272–5, 1983 May.
Savard RJ, Rey AC, Post RM: Halstead-Reitan Category Test in bipolar and unipolar affective disorders. Relationship to age and phase of illness. Journal of Nervous &; Mental Disease 168(5):297–304, 1980.
Sax KW, Strakowski SM, Keck PE Jr, McElroy SL, West SA, Stanton SP: Symptom correlates of attentional improvement following hospitalization for a first episode of affective psychosis. Biol Psychiatry 44(8):784–786, 1998.
Segal J, Berk M, Brook S: Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clinical Neuropharmacology 21:176–180, 1998.
Sharma T, Mockler D: The cognitive efficacy of atypical antipsychotics in schizophrenia. J Clin Psychopharmacol 18:12S–19S1, 1998.
Solomon DA, Ristow WR, Keller MB, Kane JM, Gelenberg AJ, Rosenbaum JF: Serum lithium levels and psychosocial function in patients with bipolar disorder. American Journal of Psychiatry 153(10):1301–7, 1996 Oct.
Sonne SC, Brady KT, Morton WA: Substance abuse and bipolar affective disorder. J Nerv Ment Dis 182:349–352, 1994.
Strakowski SM, Keck PE Jr, McElroy SL, et al. Twelve-month outcome after a first hospitalization for affective psychosis. Arch Gen Psychiatry 55:49–55, 1988.
Tham A, Engelbrektson K, Mathe AA, Johnson L, Olsson E, Aberg-Wistedt A: Impaired neuropsychological performance in euthymic patients with recurring mood disorders. Journal of Clinical Psychiatry 58:26–29, 1997.
Tohen M, Hennen J, Zarate CA Jr, Baldessarini RJ, Strakowski SM, Stoll AL, Faedda GL, Suppes T, Gebre-Medhin P, Cohen BM: The McLean First Episode Project: Two-year syndromal and functional recovery in 219 cases of major affective disorders with psychotic features. Am J Psychiatry 157:220–228, 2000.
Tohen M, Greenfield SF, Weiss RD, Zarate CA Jr, Vagge LM: The effect of comorbid substance use disorders on the course of bipolar disorder: A review. Harvard Rev Psychiatry 6:133–141, 1998a.
Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa R, Daniel D, Petty F, Centorrino F, Wang R, Grundy SL, Greaney MG, Jacobs TG, David SR, Toma V and the olanzapine HGEH study group. Am J Psychiatry 156:702–709, 1999.
Tohen M, Waternaux CM, Tsuang MT. Outcome in mania: a 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 47:1106–1111, 1990.
Tohen M, Zarate CA Jr, Centorrino F, Hegarty J, Froeschl M, Zarate SB: Risperidone in the treatment of mania. J Clin Psychiatry 57:249–253, 1996.
Tohen M, Zarate CA Jr: Antipsychotic Drugs in Bipolar Disorder. J Clin Psychiatry 59[suppl 1]:38–48, 1998b.
Tsuang MT, Woolson RF, Fleming JA: Long-term outcome of major psychoses; I: schizophrenia and affective disorders compared with psychiatrically symptom-free surgical controls. Arch Gen Psychiatry 39:1295–1301, 1979.
van Gorp WG, Altshuler L, Theberge DC, Wilkins J, Dixon W: Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. Arch Gen Psychiatry 55:41–6, 1998.
Zarate CA Jr, Narendran R, Tohen M, Greaney JJ, Berman A, Pike S, Madrid A. Clinical predictors of acute response with olanzapine in psychotic mood disorders. J Clin Psychiatry 59:24–28, 1998.
Zarate CA Jr, Tohen M, Baldessarini RJ: Clozapine in severe mood disorders. J Clin Psychiatry 56:411–417, 1995.
Zarate CA Jr, Tohen M: Antipsychotic drug treatment in first-episode mania: a 6-month longitudinal study. J Clin Psychiatry 61:33–38, 2000.